Get the Daily Brief
Latest Biotech News
FDA Approves Competing RSV Antibody Drugs Amid Advisory Committee Overhaul
Merck's RSV antibody drug Enflonsia has received FDA approval for infants under 12 months, entering a market dominated by Sanofi and AstraZeneca's Beyfortus. This approval coincides with the...